LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Latest News & Commentary

New AI Tool Maps Viral RNA in 3D at Molecular Level

Lucia Simmen Senior Digital Content Editor, Oxford Global

Transatlantic Tech Prosperity Deal to Boost Drug Discovery Efforts and Drive Employment

Lucia Simmen Senior Digital Content Editor, Oxford Global

Seaport Therapeutics’ Anxiety Drug Dosed in First Patient

Lucia Simmen Senior Digital Content Editor, Oxford Global

Researchers Engineer Self-Organising Ureter Structures from Stem Cells

Lucia Simmen Senior Digital Content Editor, Oxford Global

Mucus Microspheres Offer the Promise of Adhesive and Sustained Drug Delivery

Lucia Simmen Senior Digital Content Editor, Oxford Global

D&D LSX - Connect with Peers

Latest Technology Spotlights

Virtual Screening, Experimental Accuracy

Polysorbates And Beyond

Customised Enteric Capsules Show Promising Results For Oral Delivery Of GLP-1 RA

Targeting P2X7: Journey from Early Discovery to a Clinical-Stage Candidate

Latest News

From Drug Product Development to Overcoming Regulatory Hurdles

Intellectual Property in the Innovation Pipeline: Lessons from the “IP Considerations in Early Discovery & Development” Roundtable

Gain Therapeutics Reports Early Findings on GT-02287 in Parkinson’s Disease

Thought Leadership

Executive Interview with Shilpa Thosar, Former Executive Director, Cara Therapeutics

Shilpa Thosar Independent Consultant & Former Executive Director of Cara Therapeutics,

Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Emma Mead Chief Scientific Officer, Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

S Moein Moghimi Professor of Nanomedicine and Pharmaceutics, School of Pharmacy, Newcastle University, UK

Shadi Farhangrazi CEO, S. M. Discovery Group (SMDG)

Ralph Minter , Alchemab

Executive Interview with Joshua Baughman, Bristol Myers Squibb

Joshua Baughman Scientific Director, Bristol Myers Squibb

Advancing Drug Discovery Ebook Ad

Market Insight: Across R&D Stages

Better Antibodies for Parkinson’s Disease

Insights into Patient Resilience from Antibody Discovery

Targeting TREM2 with Bicyclic Peptides

Understanding The Role Of Microglia In Alzheimer’s Disease

From Genes to Brains: Linking Genetic Risk Factors to Neuronal Dysfunctions in Alzheimer’s Disease

A Novel Non-Degrading Molecular Glue Modality For Unlocking The Hard To Drug Proteome

Complex In Vitro Models for Immune Disease Solutions

Folding Our Way to Cancer Solutions

Harnessing AI to Discover Rare Disease Drugs

From Static to Dynamic: New Frontiers in Functional CRISPR Screens

Non-Invasive Routes For Large Molecules

Navigating Crystallisation Science In The Early Phase Of Drug Development

Breathing New Life into MDIs by Navigating the Next-Gen Propellant Shift

Reimagining Oral Delivery Of Peptide And Protein Drugs

Could Hybrid Formulation Methods Accelerate Biologics Development?